Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DyeVert™ System Use for Contrast Monitoring and Minimization in At-Risk Patients Undergoing Angiography Procedures: A Real-World Registry (DyeMINISH Registry)

NCT03825094 is registered in ClinicalTrials.gov with Osprey Medical, Inc as lead sponsor.

NCT NCT03825094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03825094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DyeVert™ System Use for Contrast Monitoring and Minimization in At-Risk Patients Undergoing Angiography Procedures: A Real-World Registry (DyeMINISH Registry)
Lead sponsor
Osprey Medical, Inc
Phase
Observational
Overall status
Unknown status
Start date
May 7, 2019
Completion date
December 31, 2023
Enrollment
10,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

patients at risk for developing contrast-induced nephropathy